SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-123758
Filing Date
2024-04-30
Accepted
2024-04-30 08:17:02
Documents
39
Period of Report
2024-04-26
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d827800d8k.htm   iXBRL 8-K 28979
2 EX-99.1 d827800dex991.htm EX-99.1 31842
6 GRAPHIC g827800ex99_1p100g1.jpg GRAPHIC 297000
7 GRAPHIC g827800ex99_1p101g1.jpg GRAPHIC 263997
8 GRAPHIC g827800ex99_1p102g1.jpg GRAPHIC 331295
9 GRAPHIC g827800ex99_1p103g1.jpg GRAPHIC 229076
10 GRAPHIC g827800ex99_1p10g1.jpg GRAPHIC 270153
11 GRAPHIC g827800ex99_1p12g1.jpg GRAPHIC 220758
12 GRAPHIC g827800ex99_1p13g1.jpg GRAPHIC 254920
13 GRAPHIC g827800ex99_1p14g1.jpg GRAPHIC 240591
14 GRAPHIC g827800ex99_1p15g1.jpg GRAPHIC 298937
15 GRAPHIC g827800ex99_1p17g1.jpg GRAPHIC 345820
16 GRAPHIC g827800ex99_1p18g1.jpg GRAPHIC 188875
17 GRAPHIC g827800ex99_1p19g1.jpg GRAPHIC 290211
18 GRAPHIC g827800ex99_1p1g1.jpg GRAPHIC 365924
19 GRAPHIC g827800ex99_1p20g1.jpg GRAPHIC 342550
20 GRAPHIC g827800ex99_1p22g1.jpg GRAPHIC 310857
21 GRAPHIC g827800ex99_1p23g1.jpg GRAPHIC 451540
22 GRAPHIC g827800ex99_1p24g1.jpg GRAPHIC 443215
23 GRAPHIC g827800ex99_1p25g1.jpg GRAPHIC 426515
24 GRAPHIC g827800ex99_1p2g1.jpg GRAPHIC 551699
25 GRAPHIC g827800ex99_1p3g1.jpg GRAPHIC 276032
26 GRAPHIC g827800ex99_1p4g1.jpg GRAPHIC 388436
27 GRAPHIC g827800ex99_1p5g1.jpg GRAPHIC 315120
28 GRAPHIC g827800ex99_1p7g1.jpg GRAPHIC 368340
29 GRAPHIC g827800ex99_1p8g1.jpg GRAPHIC 257999
30 GRAPHIC g827800ex99_1p9g1.jpg GRAPHIC 235473
  Complete submission text file 0001193125-24-123758.txt   11175237

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ikt-20240426.xsd EX-101.SCH 2856
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ikt-20240426_lab.xml EX-101.LAB 18737
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ikt-20240426_pre.xml EX-101.PRE 11712
42 EXTRACTED XBRL INSTANCE DOCUMENT d827800d8k_htm.xml XML 3768
Mailing Address 3350 RIVERWOOD PARKWAY SE, SUITE 1900 ATLANTA GA 30339
Business Address 3350 RIVERWOOD PARKWAY SE, SUITE 1900 ATLANTA GA 30339 678-392-3419
Inhibikase Therapeutics, Inc. (Filer) CIK: 0001750149 (see all company filings)

IRS No.: 263407249 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39676 | Film No.: 24894126
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)